ATE240941T1 - 1,25-dihydroxy-16,22,23-trisdehydro- cholecalciferol-derivate - Google Patents

1,25-dihydroxy-16,22,23-trisdehydro- cholecalciferol-derivate

Info

Publication number
ATE240941T1
ATE240941T1 AT97104387T AT97104387T ATE240941T1 AT E240941 T1 ATE240941 T1 AT E240941T1 AT 97104387 T AT97104387 T AT 97104387T AT 97104387 T AT97104387 T AT 97104387T AT E240941 T1 ATE240941 T1 AT E240941T1
Authority
AT
Austria
Prior art keywords
trisdehydro
dihydroxy
cholecalciferol derivatives
cholecalciferol
derivatives
Prior art date
Application number
AT97104387T
Other languages
English (en)
Inventor
Bernard Michael Hennessy
Jerome Anthony Iacobelli
Milan Radoje Uskokovic
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Application granted granted Critical
Publication of ATE240941T1 publication Critical patent/ATE240941T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C401/00—Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804—Compounds having Si-O-C linkages
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Furan Compounds (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Liquid Crystal Substances (AREA)
AT97104387T 1996-03-21 1997-03-14 1,25-dihydroxy-16,22,23-trisdehydro- cholecalciferol-derivate ATE240941T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US1380996P 1996-03-21 1996-03-21

Publications (1)

Publication Number Publication Date
ATE240941T1 true ATE240941T1 (de) 2003-06-15

Family

ID=21761865

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97104387T ATE240941T1 (de) 1996-03-21 1997-03-14 1,25-dihydroxy-16,22,23-trisdehydro- cholecalciferol-derivate

Country Status (30)

Country Link
EP (1) EP0796843B1 (de)
JP (1) JP2801587B2 (de)
KR (1) KR100240541B1 (de)
CN (1) CN1110477C (de)
AR (1) AR006315A1 (de)
AT (1) ATE240941T1 (de)
AU (1) AU708679B2 (de)
BR (1) BR9701404A (de)
CA (1) CA2199893C (de)
CO (1) CO4820396A1 (de)
CZ (1) CZ85897A3 (de)
DE (1) DE69722064T2 (de)
DK (1) DK0796843T3 (de)
ES (1) ES2198512T3 (de)
HR (1) HRP970162A2 (de)
HU (1) HUP9700609A3 (de)
ID (1) ID16285A (de)
IL (1) IL120469A0 (de)
MA (1) MA26423A1 (de)
MX (1) MX9702139A (de)
NO (1) NO971217L (de)
NZ (1) NZ314424A (de)
PE (1) PE42998A1 (de)
PL (1) PL319070A1 (de)
PT (1) PT796843E (de)
SG (1) SG70589A1 (de)
TR (1) TR199700219A3 (de)
TW (1) TW444001B (de)
YU (1) YU10397A (de)
ZA (1) ZA972302B (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9625271D0 (en) * 1996-12-04 1997-01-22 Leo Pharm Prod Ltd Chemical compounds
US6331642B1 (en) * 1999-07-12 2001-12-18 Hoffmann-La Roche Inc. Vitamin D3 analogs
KR101285720B1 (ko) * 2012-03-02 2013-07-19 주식회사 유니크메디케어 여드름 개선용 조성물
KR102493627B1 (ko) 2015-11-26 2023-01-31 코웨이 주식회사 호르데닌을 유효성분으로 함유하는 피부암 예방 또는 치료용 약학 조성물

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA8923B (en) * 1988-01-20 1989-09-27 Hoffmann La Roche 16-dehydro-vitamin d3-derivatives
EP0398217B1 (de) * 1989-05-18 1994-01-12 F. Hoffmann-La Roche Ag Dehydrocholecalciferolderivate

Also Published As

Publication number Publication date
JPH107651A (ja) 1998-01-13
SG70589A1 (en) 2000-02-22
CN1110477C (zh) 2003-06-04
AR006315A1 (es) 1999-08-25
CN1172793A (zh) 1998-02-11
CA2199893A1 (en) 1997-09-21
YU10397A (sh) 1999-07-28
EP0796843A2 (de) 1997-09-24
DE69722064D1 (de) 2003-06-26
CA2199893C (en) 2008-02-05
PT796843E (pt) 2003-09-30
KR100240541B1 (ko) 2000-01-15
AU708679B2 (en) 1999-08-12
NO971217D0 (no) 1997-03-17
HRP970162A2 (en) 1998-04-30
CZ85897A3 (cs) 1998-04-15
DE69722064T2 (de) 2004-04-08
PL319070A1 (en) 1997-09-29
MA26423A1 (fr) 2004-12-20
TR199700219A2 (xx) 1997-10-21
AU1513597A (en) 1997-09-25
IL120469A0 (en) 1997-07-13
DK0796843T3 (da) 2003-09-15
TW444001B (en) 2001-07-01
JP2801587B2 (ja) 1998-09-21
ES2198512T3 (es) 2004-02-01
TR199700219A3 (tr) 1997-10-21
ID16285A (id) 1997-09-18
BR9701404A (pt) 1998-11-03
KR970065495A (ko) 1997-10-13
HUP9700609A2 (hu) 1998-07-28
NO971217L (no) 1997-09-22
PE42998A1 (es) 1998-08-11
MX9702139A (es) 1998-04-30
CO4820396A1 (es) 1999-07-28
NZ314424A (en) 1998-07-28
ZA972302B (en) 1997-09-22
EP0796843A3 (de) 1999-04-14
HUP9700609A3 (en) 1999-03-01
HU9700609D0 (en) 1997-05-28
EP0796843B1 (de) 2003-05-21

Similar Documents

Publication Publication Date Title
DE69736711D1 (de) Substituierte 6,5-heterobicyclische-derivate
DK0925298T3 (da) Substituerede 6,6-heterobicykliske derivater
DE69933287D1 (de) 12,13-modifizierte epothilon-derivate
DK1000048T3 (da) Substituerede 1,2,3,4-tetrahydronapthalenderivater
NO2006016I1 (no) 7,8,9,10-tetrahydro-6H-6,10-metanoazepinoÄ4,5-gÜkinoksalintartrat
PT993456E (pt) 4,5-diaril-imidazoles 2-substituidos
NO983169L (no) Hetrosykel-kondenserte morfinoidderivater (31)
DE69718771D1 (de) Substituierte 1,2,3,4-tetrahydronaphthalinderivate
DE59507222D1 (de) Substituierte 1,2,3,4-tetrahydro-5-nitro-pyrimidine
ATE246199T1 (de) 3-descladinose-2,3-anhydroerythromycin-derivate
ATE227282T1 (de) 2,4-diaminopyrimidin-derivate
NO20003825L (no) 1,3,4 - oxadiazolonderivater
DE69714358T2 (de) 9,10-disubstituierte campothecinderivate mit antitumoraktivität
DE69722064D1 (de) 1,25-Dihydroxy-16,22,23-trisdehydro-Cholecalciferol-Derivate
TR28915A (tr) Naftokinon türevleri.
DK1068200T3 (da) 2,4,4-trisubstituerede-1,3-dioxolanfungicider
ID24047A (id) Turunan 5-tersubstitusi-3-oksaziazolil 1,6-naftiridin-2 1h-on
NO993024L (no) Polysakkarid-peptid-derivater
BR9508248A (pt) 1,2,4,6-Tiatriazinas herbicidas
BR9708948A (pt) 1,3 - Benzodioxois substituídos
TR199700927A3 (tr) N-Benzilazolyum türevleri.
ITMI941593A1 (it) Tetraidropiridine 3, 3-disostituite

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0796843

Country of ref document: EP

REN Ceased due to non-payment of the annual fee